Left Ventricular Dysfunction - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Left Ventricular Dysfunction -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Left Ventricular Dysfunction in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Left Ventricular Dysfunction. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Left Ventricular Dysfunction. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Left Ventricular Dysfunction sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Left Ventricular Dysfunction market.

  • Identifying prevalent patient populations as well as risk factors in the global Left Ventricular Dysfunction market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Left Ventricular Dysfunction therapeutics in each of the markets covered.

Left Ventricular Dysfunction - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Left Ventricular Dysfunction Overview
Left Ventricular Dysfunction Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Left Ventricular Dysfunction

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Left Ventricular Dysfunction
Sex-Specific Prevalent/Incident Cases of Left Ventricular Dysfunction
Disease Type Specific Prevalent/Incident Cases of Left Ventricular Dysfunction

8.Prevalent & Incident Cases by 7 MM-2015-2025
Left Ventricular Dysfunction Epidemiology of United States-2025
Left Ventricular Dysfunction Epidemiology of United Kingdom-2025
Left Ventricular Dysfunction Epidemiology of Germany-2025
Left Ventricular Dysfunction Epidemiology of France-2025
Left Ventricular Dysfunction Epidemiology of Spain-2025
Left Ventricular Dysfunction Epidemiology of Italy-2025
Left Ventricular Dysfunction Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Left Ventricular Dysfunction Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Left Ventricular Dysfunction Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Left Ventricular Dysfunction Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Left Ventricular Dysfunction Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Left Ventricular Dysfunction Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Left Ventricular Dysfunction Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Left Ventricular Dysfunction Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Left Ventricular Dysfunction Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Left Ventricular Dysfunction Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Left Ventricular Dysfunction Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Left Ventricular Dysfunction Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Left Ventricular Dysfunction Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Left Ventricular Dysfunction Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Left Ventricular Dysfunction Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Left Ventricular Dysfunction Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Left Ventricular Dysfunction (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Left Ventricular Dysfunction By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Left Ventricular Dysfunction Sub-population,Japan (2015-2025)
  • Restenosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Restenosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family hist......
  • Global Dilated Cardiomyopathy Therapeutics Market Size, Status and Forecast 2022
    Published: 08-Aug-2017        Price: US 3300 Onwards        Pages: 96
    This report studies the global Dilated Cardiomyopathy Therapeutics market, analyzes and researches the Dilated Cardiomyopathy Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Capricor Therapeutics - Zensun (Shanghai) Sci & Tech Co., Ltd. - Aastrom Biosciences - Kasiak Research Pvt. Ltd. - MyoKardia - t2cure GmbH - ... ......
  • Arrhythmias - Pipeline Review, H2 2017
    Published: 08-Aug-2017        Price: US 2000 Onwards        Pages: 46
    Arrhythmias - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias - Pipeline Review, H2 2017, provides an overview of the Arrhythmias (Cardiovascular) pipeline landscape. An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. Signs and symptoms include anxiety, weakness, dizz......
  • Atrial Fibrillation - Pipeline Review, H2 2017
    Published: 08-Aug-2017        Price: US 2000 Onwards        Pages: 88
    Atrial Fibrillation - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Pipeline Review, H2 2017, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body. Symptoms include decreased blood pressure, weakness, lightheadedness, co......
  • Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
    Published: 08-Aug-2017        Price: US 2000 Onwards        Pages: 396
    Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to ......
  • Myocarditis - Pipeline Review, H2 2017
    Published: 08-Aug-2017        Price: US 2000 Onwards        Pages: 33
    Myocarditis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis - Pipeline Review, H2 2017, provides an overview of the Myocarditis (Cardiovascular) pipeline landscape. Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reach the heart. Symptoms include chest pain, rapid or......
  • Dilated Cardiomyopathy - Pipeline Insight, 2017
    Published: 28-Jul-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Dilated Cardiomyopathy-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Dilated Cardiomyopathy. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Dilated Cardiomyopathy by development stage, therapy type, route of administration and molecule type is also covered in the ......
  • Left Ventricular Dysfunction - Pipeline Insight, 2017
    Published: 28-Jul-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Left Ventricular Dysfunction-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Left Ventricular Dysfunction. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Left Ventricular Dysfunction by development stage, therapy type, route of administration and molecule type is al......
  • Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Pipeline Insight, 2017
    Published: 28-Jul-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Peripheral Arterial Disease (PAD)/......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs